Loading…
Operator of home health, hospice and senior living services through an independent, locally-managed operating model.
Operator of home health, hospice and senior living services through an independent, locally-managed operating model.
Paid mostly by Medicare, which sets fixed payment rates per 30-day period of home health care and per day of hospice care, so government rate-setting matters. Home health and hospice carry the business, with senior living paid privately by residents. It was spun off from Ensign Group in 2019.
Moat: narrow (distribution, scale). Decentralized local-leadership model drives operational focus, though scale remains smaller than national peers.
Headquarters: Eagle, Idaho · Founded: 2019 · Employees: 9,700
Size Pennant (PNTG) is a United States Health Care company (Medical/Nursing Services) with a market value of $1.27B, the 2101st largest of 3,117 United States companies the cockpit tracks. Shares closed at $36.36 on 6 Nov 2026.
Performance Over six months the shares gained 1.3%, against +21.3% for the median peer and -1.1% for the United States market (cap-weighted) — 6th lowest of 21 in its peer set.
Growth Revenue grew 37.9% over the last twelve months (peer median +7.3%); the operating margin is 6.3% (peer median 5.0%).
Valuation It trades at 24.0× forward earnings against a peer median of 30.4× (7th cheapest of 16).
Price implies For today's price to make sense, revenue must grow about 21% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is +2 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.7 points below its cost of capital (9.8% WACC).
Short interest Short interest is 3.3% of the free float (15 Oct 2026).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $1.10B | $948M | $695M | $545M | $473M |
| Revenue growth | — | +36% | +28% | +15% | — |
| Gross profit | $144M | $122M | $87.6M | $61.9M | $53.7M |
| EBITDA | $79.6M | $65.6M | $44.3M | $30.8M | $25.4M |
| Net income | $32.3M | $29.6M | $22.6M | $13.4M | $6.64M |
| Free cash flow | $26.1M | $26.3M | $15.0M | $25.0M | -$5.13M |
| Capital expenditure | $27.2M | $22.0M | $20.4M | $8.11M | $14.2M |
| Total debt | $496M | $460M | $273M | $330M | $327M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Pennant PNTG | $1.27B | +1% | +38% | 6% | 24.0× | 21.1% |
| Addus HomeCare ADUS | $2.32B | +25% | +12% | 11% | 16.6× | 4.9% |
| Brookdale Senior Living BKD | $2.15B | -31% | -4% | 5% | 127.7× | 22.4% |
| Encompass Health EHC | $13.5B | +30% | +9% | 18% | 20.5× | 5.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PNTG | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -9.9% | +5.9% | 2nd lowest of 21 |
| 6-month return | +1.3% | +21.3% | 6th lowest of 21 |
| Distance from 52-week high | -17.8% | -16.0% | 10th lowest of 21 |
| Revenue growth (TTM) | +37.9% | +7.3% | 2nd highest of 21 |
| Operating margin | 6.3% | 5.0% | 10th highest of 21 |
| Forward P/E | 24.0× | 30.4× | 7th cheapest of 16 |
| Growth the price implies (Req g, 7 yrs) | 21.1% | 14.8% | 5th most demanding of 17 |
| Growth delivered (Del g) | +19.4% | +11.8% | 4th highest of 17 |
| Hurdle (Req g minus delivered) | +1.7 pp | +3.5 pp | 9th least demanding of 17 |
| ROIC minus cost of capital | -3.7 pp | -3.1 pp | 10th lowest of 20 |
| EV / EBITDA | 22.6× | 11.6× | 7th most expensive of 17 |
| Net debt / EBITDA | 6.0× | 1.3× | 4th most indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Pennant PNTG | United States | $1.27B | +1% | +38% | 6% | 24.0× | 21.1% | +19.4% |
| Metropolis Healthcare METROPOLIS.NS | India | $1.25B | +12% | +20% | 18% | 45.6× | 32.4% | +10.5% |
| Lumexa Imaging LMRI | United States | $1.29B | +29% | +8% | 3% | 18.6× | n/a | n/a |
| OPKO Health OPK | United States | $1.29B | +52% | -11% | -29% | n/a | n/a | n/a |
| Diagnostyka DIA.WA | Poland | $1.29B | -5% | +19% | 15% | 18.4× | 6.9% | +18.9% |
| Nutex Health NUTX | United States | $1.24B | +32% | +7% | 43% | 7.2× | -19.5% | +253.5% |
| GoodRx GDRX | United States | $1.20B | +20% | -2% | 12% | 10.4× | 6.8% | +7.7% |
| H.U.Group 4544.T | Japan | $1.35B | +24% | +1% | 2% | 41.0× | 10.1% | +2.1% |
| Novogene 688315.SS | China | $1.16B | +31% | +6% | 7% | 35.7× | 17.1% | +8.2% |
| Clariane CLARI.PA | France | $1.40B | -20% | +1% | 6% | 8.6× | 6.7% | +6.5% |
| U.S. Physical Therapy USPH | United States | $1.48B | +68% | +11% | 10% | 30.4× | 19.9% | +13.0% |
| Regis Healthcare REG.AX | Australia | $1.05B | -17% | +17% | 4% | 25.1× | 14.6% | +14.4% |
| Sonida Senior Living SNDA | United States | $1.58B | -14% | +49% | -11% | n/a | n/a | n/a |
| Teladoc Health TDOC | United States | $1.60B | +21% | -2% | -5% | n/a | -5.2% | +18.3% |
| Vijaya Diagnostic Centre VIJAYA.NS | India | $1.60B | +22% | +24% | 32% | 64.3× | 39.3% | +16.7% |
| AdaptHealth AHCO | United States | $1.00B | +8% | -3% | 3% | n/a | 16.3% | +25.2% |
| Ambea AMBEA.ST | Sweden | $1.63B | +30% | +13% | 8% | 15.8× | 1.7% | +7.7% |
| Ping An Healthcare and Technology 1833.HK | Hong Kong | $1.63B | -47% | +8% | 3% | 40.1× | 15.0% | -5.1% |
| Personalis PSNL | United States | $1.71B | +164% | -13% | -164% | n/a | n/a | n/a |
| Azenta AZTA | United States | $1.72B | +104% | +1% | -3% | 103.7× | 56.0% | +8.9% |
| Dr. Agarwal's Health Care AGARWALEYE.NS | India | $1.74B | +15% | +22% | 15% | 89.1× | 41.9% | +26.9% |